Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation.
Iannetta M, Zingaropoli MA, Bellizzi A, Morreale M, Pontecorvo S, D'Abramo A, Oliva A, Anzivino E, Lo Menzo S, D'Agostino C, Mastroianni CM, Millefiorini E, Pietropaolo V, Francia A, Vullo V, Ciardi MR.
Iannetta M, et al. Among authors: pontecorvo s.
PLoS One. 2016 Aug 3;11(8):e0160277. doi: 10.1371/journal.pone.0160277. eCollection 2016.
PLoS One. 2016.
PMID: 27486658
Free PMC article.
Clinical Trial.